Vesivax TLR7 formula
Active Definitive Contract Awarded Last action
- Contract number
- 75N93024C00017
- Awardee
-
Molecular Express, Inc. UEI R1JMHFESEKD5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,999,352
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · PHS20241 · Posted Jul 7, 2023
- Contract value 100% obligated
- $2,999,352.00 Current and potential, with all options
- Completion date 72% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 16 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- CRYSTAL CITY, CA 90220, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $2,999,352 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a $3 million definitive contract to Molecular Express, Inc., a minority-owned small disadvantaged business, for VESIVAX TLR7 formula development on September 1, 2024, with an ultimate completion date of August 31, 2027.
The originating solicitation, posted as a total small business set-aside pre-solicitation on July 7, 2023, sought development of the VESIVAX TLR7 formula. Place of performance is Crystal City, California. The contract is firm fixed price.
Through fiscal year 2025, Molecular Express has invoiced $1.25 million against the $3 million ceiling. Labor has ramped from 0.3 FTEs and 662 contractor hours in FY2024 (at a derived rate of $377.45 per hour) to 1.0 FTEs in FY2025. The awardee self-performed all reported hours with no subcontractors.
Quick answers
Who was awarded contract 75N93024C00017?
75N93024C00017 was awarded to Molecular Express, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2024.
How much is contract 75N93024C00017 worth?
The government has obligated $2,999,352 on 75N93024C00017.
Was contract 75N93024C00017 competed?
The extent of competition for 75N93024C00017 was full and open competition. The government received 16 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award